Current Research: Closed System Transfer Devices Market Detailed Product of Potential Growth and Forecasts
Impact of Covid-19 on Closed System Transfer Device Market
The outbreak of COVID-19 lead to the decrease in the demand of CSTDs during the first two quarters of 2020. Due to the virus containment norms and nationwide lockdowns, there were limited patient footfalls in hospitals, mostly related to COVID-19 and emergency cases. The elective medical procedures on hold thereby causing a negative shift in the demand of CSTDs. However, with the decline in the number of active COVID-19 cases coupled with the economic recovery in developed nations, further utilization of these devices may be expected in the near future.
Get PDF Brochure:
领英推荐
DRIVERS:?Increasing use of CSTDs to combat harmful effects of cytotoxic and antineoplastic drugs
Antineoplastic drugs are widely used in the treatment of cancer and are considered as hazardous drugs.Healthcare workers involved in the preparation, transport, distribution, administration (pre- and post-administration), and disposal of these drugs are at extremely high risk. The National Institute for Occupational Safety and Health (NIOSH) recommends the use of CSTDs to eliminate the harmful effects caused by the exposure to harzadous substances that escape out of the system during drug preparation and administration. CSTDs act as a barrier and prevents the entry of contaminants prevent the transfer of contaminants from atmosphere to sterile environment. Owing to these advantages, CSTDs are increasingly being used in healthcare facilities to combat the harmful effects of hazardous drugs.
Get Sample Request:
OPPORTUNITY: Increasing application of CSTDs in other therapeutic areas
CSTDs are majorly used to protect healthcare workers during the preparation and administration of antineoplastic drugs in chemotherapy. However, breath of application of these devices is increasing with increasing use in the treatment of various non-cancerous diseases such as rheumatoid arthritis, multiple sclerosis, psoriasis, and systemic lupus erythematosus. Non-cytotoxic drugs used to treat various conditions also fall under the category of hazardous drugs. Examples include Bacillus of Calmette, the Guerin strain of Mycobacterium Bovis (BCG), and monoclonal antibodies. The increase in the therapeutic applications of these drugs offers potential growth opportunities in the coming years.